sulfinpyrazone has been researched along with Basophilic Leukemia, Acute in 1 studies
Sulfinpyrazone: A uricosuric drug that is used to reduce the serum urate levels in gout therapy. It lacks anti-inflammatory, analgesic, and diuretic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millard, PJ | 1 |
| Ryan, TA | 1 |
| Webb, WW | 1 |
| Fewtrell, C | 1 |
1 other study available for sulfinpyrazone and Basophilic Leukemia, Acute
| Article | Year |
|---|---|
Immunoglobulin E receptor cross-linking induces oscillations in intracellular free ionized calcium in individual tumor mast cells.
Topics: Adenosine Triphosphate; Animals; Antigens, Differentiation, B-Lymphocyte; Benzofurans; Calcium; Cell | 1989 |